PPT1 and glycogen storage disease VI: As far as safety is concerned, busulfan conditioning was feasible in CLN1 disease mice (despite the well‐known pro‐epileptogenic potential of this drug) (Caselli et al, 2014), provided that anti‐seizure prophylaxis (e.g., benzodiazepine) is administered before and during the conditioning.